HomeAURA • NASDAQ
add
Aura Biosciences Inc
Previous close
$5.68
Day range
$5.43 - $5.71
Year range
$4.35 - $11.29
Market cap
339.17M USD
Avg Volume
265.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.61M | 25.71% |
Net income | -27.02M | -32.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -28.33M | -26.18% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 177.31M | -5.39% |
Total assets | 204.40M | -6.36% |
Total liabilities | 29.77M | 10.96% |
Total equity | 174.63M | — |
Shares outstanding | 62.12M | — |
Price to book | 2.02 | — |
Return on assets | -39.76% | — |
Return on capital | -42.18% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -27.02M | -32.86% |
Cash from operations | -20.77M | -28.81% |
Cash from investing | 19.98M | 0.69% |
Cash from financing | 69.93M | 84,151.81% |
Net change in cash | 69.14M | 1,721.42% |
Free cash flow | -11.26M | -21.78% |
About
Founded
2009
Headquarters
Website
Employees
106
